Cidara Therapeutics Inc (CDTX)
23.22
+0.71
(+3.15%)
USD |
NASDAQ |
Dec 20, 16:00
23.26
+0.04
(+0.17%)
After-Hours: 20:00
Cidara Therapeutics Price to Book Value: 2.197 for Dec. 20, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.313 |
| Arbutus Biopharma Corp | 5.691 |
| GlycoMimetics Inc | 1.325 |
| FibroGen Inc | -- |
| Cue Biopharma Inc | 2.560 |
Price to Book Value Related Metrics
| PS Ratio | 1.907 |
| PEG Ratio | -0.0012 |
| Price | 23.22 |
| Earnings Yield | -109.2% |
| Market Cap | 254.00M |
| PEGY Ratio | -0.0012 |